119 related articles for article (PubMed ID: 528491)
21. [Exploration of hepato-biliary function with I-131 labeled BSF. II. Hepato-biliary dynamic scintiscanning].
Quattrocchi G; Squillaci S; Grasso E; Arcoraci A
Boll Soc Ital Biol Sper; 1974 Aug; 50(13):924-9. PubMed ID: 4463980
[No Abstract] [Full Text] [Related]
22. Low incidence of post-transfusion hepatitis in patients with liver cirrhosis.
Watanabe A; Fujiwara M; Kobayashi M; Nakatsukasa H; Higashi T; Hashimoto M; Yamauchi Y; Nagashima H
Hepatogastroenterology; 1986 Jun; 33(3):95-7. PubMed ID: 3091470
[TBL] [Abstract][Full Text] [Related]
23. [The role of the serum BG(P-B) value from glucagon loading test in assessing liver function of cirrhosis patients].
Wu BF; Lin LL; Hu PJ
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):186. PubMed ID: 12681076
[No Abstract] [Full Text] [Related]
24. [Study of hepatic parenchymatous function. Contribution of the galactose clearance test. Study by multidimensional statistical analysis].
Hecht Y; Ben Amar A; Touboul JP; el-Guedry H; Salmon D; Nakache JP
Nouv Presse Med; 1972 Dec; 1(46):3133-4. PubMed ID: 4650517
[No Abstract] [Full Text] [Related]
25. [Various indicators of blood coagulation in the evaluation of liver function in different clinical forms of viral hepatitis].
Janeczko J; Babiuch L; Górska E; Olejnik Z
Przegl Epidemiol; 1981; 35(4):463-9. PubMed ID: 7339706
[No Abstract] [Full Text] [Related]
26. [Study of rose bengal-I-131 and Au198 clearance in liver cirrhosis, pulmonary tuberculosis and renal tuberculosis].
Ginzburg VS
Med Radiol (Mosk); 1973 Aug; 18(8):59-61. PubMed ID: 4799535
[No Abstract] [Full Text] [Related]
27. [Therapeutic effects of calcium-2,2'-disulfohexanoate in hepatic cirrhosis].
Cangiano C; Angelico M; Rossi Fanelli F
Clin Ter; 1978 Aug; 86(4):337-53. PubMed ID: 737963
[No Abstract] [Full Text] [Related]
28. [Comparative evaluation of liver function tests in convalescents following infectious hepatitis].
Gorodetskiĭ IaI; Filius MI
Vrach Delo; 1973 Jul; 7(7):133-5. PubMed ID: 4756034
[No Abstract] [Full Text] [Related]
29. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics.
Tietge UJ; Böker KH; Manns MP; Bahr MJ
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E82-9. PubMed ID: 15010338
[TBL] [Abstract][Full Text] [Related]
30. [Triglyceridemia in liver cirrhosis].
Swynghedauw B
Ann Biol Clin (Paris); 1971; 29(5):393-6. PubMed ID: 5145639
[No Abstract] [Full Text] [Related]
31. Hepatic function and portal hemodynamics in patients with liver cirrhosis.
Kawasaki T; Moriyasu F; Kimura T; Someda H; Tamada T; Yamashita Y; Ono S; Kajimura K; Hamato N; Okuma M
Am J Gastroenterol; 1990 Sep; 85(9):1160-4. PubMed ID: 2202201
[TBL] [Abstract][Full Text] [Related]
32. [On the prognostic value of several hepatic function tests in liver cirrhosis].
Zannini L; Palleschi A
Friuli Med; 1967; 22(4):895-910. PubMed ID: 5596251
[No Abstract] [Full Text] [Related]
33. [Bromosulphophthalein test in rheumatoid arthritis and in rheumatic fever].
Gietka J; Symonowicz N
Wiad Lek; 1969 Apr; 22(7):629-33. PubMed ID: 5768746
[No Abstract] [Full Text] [Related]
34. [Study of hepatic function by galactose and bromosulfophthalein: their reciprocal interference].
Spandri P; Dal Palù C; Zuin R
Sem Hop; 1967 Sep; 43(38):2304-8. PubMed ID: 4294090
[No Abstract] [Full Text] [Related]
35. [The validity of wofaverdin retention for the evaluation of the liver function].
Rose W
Dtsch Z Verdau Stoffwechselkr; 1968; 28(2):183-4. PubMed ID: 5732393
[No Abstract] [Full Text] [Related]
36. [Changes of hepatic functions in obese persons].
Horký J; Rath R; Slabochová Z; Blahníková L
Cesk Gastroenterol Vyz; 1971 Apr; 25(3):98-103. PubMed ID: 5566379
[No Abstract] [Full Text] [Related]
37. Verapamil pharmacokinetics and liver function in patients with cirrhosis.
Finucci GF; Padrini R; Piovan D; Melica E; Merkel C; Gatta A; Zuin R
Int J Clin Pharmacol Res; 1988; 8(2):123-6. PubMed ID: 3378854
[TBL] [Abstract][Full Text] [Related]
38. Fractional clearance of bromosulfonephthalein and metabolic clearance of antipyrine. Correlative study in liver diseases.
Couet C; Brissot P; Messner M; Delamaire D; Gie S; Bourel M
Ann Gastroenterol Hepatol (Paris); 1984; 20(1):1-6. PubMed ID: 6529154
[TBL] [Abstract][Full Text] [Related]
39. [The leper's liver].
Languillon J; Plagnol H; Saboret J; Gayraud J; Giraudeau P
Bull Soc Pathol Exot Filiales; 1966; 59(1):22-31. PubMed ID: 6012575
[No Abstract] [Full Text] [Related]
40. [Absorption of vofaverdin by the liver in circulatory insufficiency, chronic hepatitis and liver cirrhosis].
Fomichev VI
Klin Med (Mosk); 1973 Oct; 51(10):94-6. PubMed ID: 4787288
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
